Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
0.715
-0.009 (-1.23%)
At close: Dec 20, 2024, 4:00 PM
0.642
-0.073 (-10.17%)
After-hours: Dec 20, 2024, 7:55 PM EST
Lexicon Pharmaceuticals Employees
Lexicon Pharmaceuticals had 285 employees as of December 31, 2023. The number of employees increased by 150 or 111.11% compared to the previous year.
Employees
285
Change (1Y)
150
Growth (1Y)
111.11%
Revenue / Employee
$18,347
Profits / Employee
-$759,274
Market Cap
258.36M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Accolade | 2,400 |
Zynex | 1,100 |
OraSure Technologies | 638 |
Amylyx Pharmaceuticals | 384 |
Vanda Pharmaceuticals | 203 |
AC Immune | 161 |
Senseonics Holdings | 132 |
Atea Pharmaceuticals | 75 |
LXRX News
- 1 day ago - US FDA declines to approve Lexicon Pharma's add-on diabetes drug - Reuters
- 1 day ago - Lexicon Announces Receipt of Complete Response Letter for Zynquista™ (sotagliflozin) - GlobeNewsWire
- 25 days ago - Lexicon Announces Completion of Enrollment in Phase 2B PROGRESS Study of LX9211 in Diabetic Peripheral Neuropathic Pain (DPNP) - GlobeNewsWire
- 26 days ago - Lexicon Pharmaceuticals to Participate in December Investor Conferences - GlobeNewsWire
- 4 weeks ago - Lexicon Pharmaceuticals to cut workforce by 60% to focus on drug development - Reuters
- 4 weeks ago - Lexicon to Reposition as Clinical Development-Focused Company Following Regulatory Update From FDA - GlobeNewsWire
- 4 weeks ago - Lexicon Appoints Ivan H. Cheung to Board of Directors - GlobeNewsWire
- 5 weeks ago - Lexicon Pharmaceuticals, Inc. (LXRX) Q3 2024 Earnings Call Transcript - Seeking Alpha